In vivo overexpression of IL-13 receptor alpha2 chain inhibits tumorigenicity of human breast and pancreatic tumors in immunodeficient mice.
about
Biofunctionalized magnetic-vortex microdiscs for targeted cancer-cell destruction.Therapeutic efficacy of Cintredekin Besudotox (IL13-PE38QQR) in murine lung fibrosis is unaffected by immunity to Pseudomonas aeruginosa exotoxin A.A high-performance nanobio photocatalyst for targeted brain cancer therapy.A new drug delivery method of bispecific ligand-directed toxins, which reduces toxicity and promotes efficacy in a model of orthotopic pancreatic cancer.Interleukin-13 receptor α2 DNA prime boost vaccine induces tumor immunity in murine tumor modelsEnhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential.Human Hematopoietic Signal peptide-containing Secreted 1 (hHSS1) modulates genes and pathways in glioma: implications for the regulation of tumorigenicity and angiogenesis.IL-13Rα2 mediates PNR-induced migration and metastasis in ERα-negative breast cancer.Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation.Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy.Lysophosphatidic acid induces interleukin-13 (IL-13) receptor alpha2 expression and inhibits IL-13 signaling in primary human bronchial epithelial cellsCommonality of the IL-4/IL-13 pathway in atopic diseases.G-CSF rescues tumor growth and neo-angiogenesis during liver metastasis under host angiopoietin-2 deficiency.The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer.Interleukin-13 receptor alpha 2 cooperates with EGFRvIII signaling to promote glioblastoma multiforme.Potent antitumor activity of IL-13 cytotoxin in human pancreatic tumors engineered to express IL-13 receptor alpha2 chain in vivo.
P2860
Q30492872-EC2EF135-6BF5-4A95-A529-B178CE26B51DQ33525571-A6A9FC9C-4BE2-4F8C-8CB0-778DCFF791FBQ33606437-EC16A431-D8E8-47A2-A51E-8A74EB1107F9Q34009357-DD5AEC1F-8AE0-43ED-A101-C537CD337B8BQ34360520-BB783D6C-7D67-4813-A2E2-E3700BDBF1E8Q34540077-34EC6082-E247-45D7-9E98-E89A453C3734Q34969354-11124067-0ECF-4914-9D19-8164864FC7A8Q35064635-3EC39079-3870-42C5-8315-0A81D8838EF1Q35584244-000EB639-E19E-44F4-BB8C-896FB6DB7839Q36478656-63ED1B3F-0E27-4098-A45A-F54319B2A429Q37137670-C7A04C50-06F9-45F3-98CD-E772C6D5B182Q39170851-1DD62C5D-AED8-496A-950E-34F48FD8B82BQ39331096-876A060C-DB4E-4188-9B8C-857E6A089AC9Q39561301-6241E7D9-F933-4BAC-B1BE-6E64CDD4BDF1Q45074720-C25A3470-3A69-4054-93E5-5202E98BF73CQ45862963-2ACF7614-315B-4270-9F11-A9773E3B0DA8
P2860
In vivo overexpression of IL-13 receptor alpha2 chain inhibits tumorigenicity of human breast and pancreatic tumors in immunodeficient mice.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
In vivo overexpression of IL-1 ...... umors in immunodeficient mice.
@ast
In vivo overexpression of IL-1 ...... umors in immunodeficient mice.
@en
type
label
In vivo overexpression of IL-1 ...... umors in immunodeficient mice.
@ast
In vivo overexpression of IL-1 ...... umors in immunodeficient mice.
@en
prefLabel
In vivo overexpression of IL-1 ...... umors in immunodeficient mice.
@ast
In vivo overexpression of IL-1 ...... umors in immunodeficient mice.
@en
P2093
P2860
P356
P1476
In vivo overexpression of IL-1 ...... umors in immunodeficient mice.
@en
P2093
P2860
P304
P356
10.1084/JEM.194.12.1743
P407
P577
2001-12-01T00:00:00Z